# Optimal Duration of DAPT Following Treatment With Endeavor (Zotarolimus-eluting Stent) in Real-world Japanese Patients

> **NCT01325935** · PHASE4 · COMPLETED · sponsor: **Associations for Establishment of Evidence in Interventions** · enrollment: 1187 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT01325935
- **Lead sponsor:** Associations for Establishment of Evidence in Interventions
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2013-09
- **Final completion:** 2013-12
- **Target enrollment:** 1187 (ACTUAL)
- **Last updated:** 2016-01-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01325935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01325935, "Optimal Duration of DAPT Following Treatment With Endeavor (Zotarolimus-eluting Stent) in Real-world Japanese Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01325935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*